Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone

Pediatric Nephrology

Volumn 19, Issue 1, 2004, Pages 71-76

  Picca, Stefano ^a   Cappa, Marco ^a   Martinez, Chiara ^a   Moges, Seyoum Ido ^b   Osborn, John ^b   Perfumo, Francesco ^c   Ardissino, Gianluigi ^d   Bonaudo, Roberto ^e   Montini, Giovanni ^f   Rizzoni, Gianfranco ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d PARKINSON INSTITUTE   (Italy)

^e REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chronic renal failure; Growth hormone; Hyperparathyroidism; Puberty

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; AGE; ARTICLE; CALCIUM BLOOD LEVEL; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEVELOPMENTAL STAGE; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIPLE REGRESSION; OBSERVATION; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; RETROSPECTIVE STUDY; UREMIA;

CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH HORMONE; HUMANS; HYPERPARATHYROIDISM; ITALY; KIDNEY FAILURE, CHRONIC; MALE; PARATHYROID HORMONE; PUBERTY; RETROSPECTIVE STUDIES; TIME FACTORS; UREMIA;

EID: 0346007905     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1283-1     Document Type: Article

References (38)

1. Lanes R, Gunczler P, Esaa S, Weisinger JR (2002) The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study. Clin Endocrinol (Oxf) 57:725-730
2. Degerblad M, Bengtsson BA, Bramnert M, Johnell O, Manhem P, Rosen T, Thoren M (1995) Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol 133:180-188
3. Mauras N, Doi SQ, Shapiro JR (1996) Recombinant human insulin-like growth factor I, recombinant human growth hormone and sex steroids: effects on markers of bone turnover in humans. J Clin Endocrinol Metab 81:2222-2226
4. Balducci R, Toscano V, Pasquino AM, Mangiantini A, Municchi G, Armeniser P, Terracina S, Prossomariti G, Boscherini B (1995) Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. Eur J Endocrinol 132:42-46
5. Nielsen HK, Jorgensen JO, Brixen K, Christiansen JS (1991) Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH. Calcif Tissue Int 48:82-87
6. Lanes, Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M (1992) Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh) 126:387-393
7. Monson JP, Drake WM, Carroll PV, Weaver JU, Rodriguez-Arnao J, Savage MO (2002) Influence of growth hormone on accretion of bone mass. Horm Res 58 [Suppl 1]:52-56
8. Saggese G, Igli Baroncelli G, Bertelloni S, Cinquanta L, Di Nero G (1993) Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 122:37-44
9. Stamoyannou L, Karachaliou F, Gioureli E, Voskaki E, Mengreli C, Bartsocas CS, Koutselinis A (1997) Effect of growth hormone therapy on bone metabolism of growth hormone deficient children. Eur J Pediatr 156:592-596
10. Lanzi R, Losa M, Villa I, Gatti E, Sirtori M, Dal Fiume C, Rubinacci A (2003) GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults. Eur J Endocrinol 148:185-191
11. Bérard E, Crosmer H, Six-Beneton A, Chevallier T, Cochat P, Broyer M on behalf of the French Society of Pediatric Nephrology (1998) Recombinant human growth hormone treatment of children on hemodialysis. Pediatr Nephrol 12:304-310
12. Maxwell H, Rees L for the British Association for Paediatric Nephrology (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. Arch Dis Child 79:481-487
13. Sieniawska M, Panczyk-Tomaszewska M, Ziolkowska H, Cholewinski M (1996) Optimal vitamin D adjustment following recombinant human growth hormone. Proceedings of the 3rd Novo Nordisk Workshop on CRI, 28 August 1996. Lausanne, Switzerland, pp 38-43
14. Tönshoff B, Haffner D, Mehls O, Dietz M, Ruder H, Blum WF, Heinrich U, Stöver B and Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts (1993) Efficacy and safety of growth hormone treatment in short children with renal allografts: three years experience. Kidney Int 44:199-207
15. Hokken-Koelega ACS, Stijnen T, De Jong MCJW, Donckerwolcke RA, De Muinck Keizer-Schrama SMPF, Blum WF, Drop SLS (1994) Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency. J Clin Endocrinol Metab 79:1185-1190
16. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J (2000) Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 14:701-706
17. Kaufman DB (1998) Growth hormone and renal osteodystrophy: a case report. Pediatr Nephrol 12:157-159
18. Picca S, Perruzza I, Cappa M, Rizzoni G (1997) Secondary hyperparathyroidism is not always an obstacle to improved growth during recombinant human growth hormone treatment (letter). Nephron 75:239-240
19. Langman CB, Sailer DE, Cohn RA, Mendley SR, Schnaper HW, Schmeissing KA, Misiewicz MT, Marousek M (1995) Induction of secondary hyperparathyroidism (HPT) with recombinant human growth hormone (rhGH) in growth-stunted children with chronic renal diseases (CRD) (abstract). J Am Soc Nephrol 6:966
20. Fujisawa Y, Kida K (1996) Effect of growth hormone (GH) therapy on parathyroid hormone metabolism in a girl with GH deficient short stature and chronic renal failure. J Pediatr Endocrinol Metab 9:555-558
21. Picca S, Cappa M, Rizzoni G (2000) Hyperparathyroidism during growth hormone treatment: a role for puberty? Pediatr Nephrol 14:56-58
22. Watkins SL (1996) Bone disease in patients receiving growth hormone. Kidney Int 49 [Suppl 53]:S126-S127
23. Tanner JM (1962) Growth and adolescence, 2nd edn. Blackwell, Oxford
24. Ohlsson C, IsgaardJ, Tornell J, Nilsson A, Isaksson OGP, Lindahl A (1993) Endocrine regulation of longitudinal bone growth. Acta Paediatr [Suppl] 391:33-40
25. Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R (2000) Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Min Res 15:2245-2250
26. Krabbe S, Transbol I, Christiansen C (1982) Bone mineral homeostasis, bone growth and mineralisation during years of pubertal growth: a unifying concept. Arch Dis Child 57:359-363
27. Tommasi M, Bacciottini L, Benucci A, Brocchi A, Passeri A, Saracini D, D'Agata A, Cappelli G (1996) Serum biochemical markers of bone turnover in healthy infants and children. Int J Biol Markers 11:159-164
28. Norris SA, Pettifor JM, Gray DA, Buffenstein R (2001) Calcium metabolism and bone mass in female rabbits during skeletal maturation: effects of dietary calcium intake. Bone 29:62-69
29. Bonofiglio D, Maggiolini M, Catalano S, Marsico S, Aquila S, Giomo A, Andò S (2000) Parathyroid hormone is elevated but bone markers and density are normal in young female subjects who consume inadequate dietary calcium. Br J Nutr 84:111-116
30. Behnke B, Kemper M, Kruse HP, Müller-Wiefel DE (1998) Bone alkaline phosphatase in children with chronic renal failure. Nephrol Dial Transplant 13:662-667
31. Sanchez CP, Salusky IB, Kuizon DB, Abdella P, Juppner H, Goodman WG (1998) Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54:1879-1887
32. Haffner D, Schaefer F, Nissel R, Wuhl E, Tönshoff B, Mehls O for the German Study Group for Growth Hormone Treatment in Chronic Renal Failure (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. N Engl J Med 343:923-930
33. Arisaka O, Arisaka M, Nakayama Y, Fujiwara S, Yabuta K (1995) Effect of testosterone on bone metabolism in adolescent male hypogonadism. Metabolism 44:419-423
34. Schaefer F, Veldhuis JD, Stanhope R, Jones J, Schärer K and the Cooperative Study Group on Pubertal Development in Chronic Renal Failure (1994) Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. J Clin Endocrinol Metab 78:1298-1306
35. Freundlich M, Leal D, Levis S, Montane B, Abitbol C, Strauss J, Zilleruelo G (1999) Peak bone mass (PBM) following long-term pediatric dialysis therapy: a possible protective role for sex-steroid hormones (abstract). J Am Soc Nephrol 10:598A
36. Panczyk-Tomaszewska M, Ziolkowska H, Debinski A, Sawicki A, Zurowska A, Pietrzyk JA, Roszkowska-Blaim M (2000) Bone metabolism markers and bone histomorphometry in children with chronic renal failure in predialysis period during growth hormone treatment. Pol Merkuriusz Lek 8:264-265
37. Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975-982
38. Panczyk-Tomaszewska M, Ziolkowska H, Debinski A, Sieniawska M (2000) Vitamin D metabolite requirement in dialysed children receiving recombinant human growth hormone. Nephrol Dial Transplant 15:375-378